Notify me when Mark Kirschbaum files a new Insider Trading report.
⭐ Subscribe ⭐| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| CYCC, CYCCP | Cyclacel Pharmaceuticals, Inc. | Chief Medical Officer | Jun 30, 2023 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|